$NGM NGM BIOPHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NGM BIOPHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in NGM BIOPHARMACEUTICALS INC for free.

CIK Number: 0001426332
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NGM
Company Address: 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080
Phone number: 650-243-5555

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its lead product candidate, aldafermin, is designed for the treatment of patients with non-alcoholic steatohepatitis, with liver fibrosis stage 2, 3, or 4. The company was founded by Jin-Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.

NGM BIOPHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
CHEN JIN-LONGChief Scientific Officer920,0050shares bought: 395,030 / shares sold: -351,530 BUYMay 04 20212 months ago
Ho CaroleDirector00Jun 10 202111 days ago
LESCHLY MARKDirector3,766,6670shares bought: 3,766,667 / shares sold: 0 BUYJun 10 202111 days ago

View all NGM BIOPHARMACEUTICALS INC insiders.

NGM BIOPHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 10 2021NGMNGM BIOPHARMACEUTI ...LESCHLY MARKDirectorOption ExerciseA17.2419,619338,23219,619
Jun 10 2021NGMNGM BIOPHARMACEUTI ...Ho CaroleDirectorOption ExerciseA17.2419,619338,23219,619
May 04 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...SellS27.6225,000690,500920,005945 K to 920 K (-2.65 %)
Apr 13 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...SellS24.6525,000616,250945,005970 K to 945 K (-2.58 %)
Mar 18 2021NGMNGM BIOPHARMACEUTI ...Pierce Valerie LSVP, GC & CCOOption ExerciseA31.93100,0003,193,000100,000
Mar 18 2021NGMNGM BIOPHARMACEUTI ...Lieu Hsiao DSVP, Chief Medical ...Option ExerciseA31.93100,0003,193,000100,000
Mar 18 2021NGMNGM BIOPHARMACEUTI ...Nolan Mangini SiobhanChief Financial Off ...Option ExerciseA31.9350,0001,596,50050,000
Mar 18 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...Option ExerciseA31.93175,0005,587,750175,000
Mar 18 2021NGMNGM BIOPHARMACEUTI ...WOODHOUSE DAVID JChief Executive Off ...Option ExerciseA31.93450,00014,368,500450,000
Mar 18 2021NGMNGM BIOPHARMACEUTI ...RIEFLIN WILLIAM JLExecutive ChairmanOption ExerciseA31.9380,0002,554,40080,000
Mar 02 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...SellS26.6625,000666,500970,005995 K to 970 K (-2.51 %)
Feb 03 2021NGMNGM BIOPHARMACEUTI ...Nolan Mangini SiobhanChief Financial Off ...Option ExerciseA18.88300,0005,664,000300,000
Feb 03 2021NGMNGM BIOPHARMACEUTI ...Nolan Mangini SiobhanChief Financial Off ...Option ExerciseA18.88300,0005,664,000300,000
Jan 06 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...Option ExerciseM0.60150,00090,0000
Jan 06 2021NGMNGM BIOPHARMACEUTI ...CHEN JIN-LONGChief Scientific Of ...BuyM0.60150,00090,0001,020,005870 K to 1 M (+17.24 %)

View all NGM BIOPHARMACEUTICALS INC insider transactions.